The latest price target for Nutex Health (NASDAQ:NUTX) was reported by Maxim Group on September 18, 2024. The analyst firm set a price target for $45.00 expecting NUTX to rise to within 12 months (a possible 83.67% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Nutex Health (NASDAQ:NUTX) was provided by Maxim Group, and Nutex Health initiated their buy rating.

There is no last upgrade for Nutex Health

There is no last downgrade for Nutex Health.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nutex Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nutex Health was filed on September 18, 2024 so you should expect the next rating to be made available sometime around September 18, 2025.

While ratings are subjective and will change, the latest Nutex Health (NUTX) rating was a initiated with a price target of $0.00 to $45.00. The current price Nutex Health (NUTX) is trading at is $24.50, which is within the analyst’s predicted range.